Feasibility Study of Intraperitoneal Paclitaxel
NCT01739894
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Gastric Cancer
Interventions
DRUG:
IP Paclitaxel
Sponsor
National University Hospital, Singapore